D.C. biotech scores FDA approval for key drug, stock surges

The agency ’s nod “significantly increases the commercial opportunity” for the treatment of bipolar disorder, the company said.

Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 3, 2024 Category: Pharmaceuticals Authors: Sara Gilgore Source Type: news